GLAXO latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.
As of Sep 2026, promoters held 75% of GlaxoSmithKline Pharmaceuticals Ltd, FIIs 4.75%, DIIs 8.47%, government 0% and the public 11.77%, across 1,19,337 shareholders.